Interestingly, both p53 and FOXO control a distinct set of genes that are not targets of Nrf-2 activity, even though all three factors induce HO-1 expression and Fe2+ storage and secretion, which is known to play a role in breast cancer progression [252]. The gene discussed is TP53; the disease is breast carcinoma.